Daniel Ferry
LifeSci Advisors
Replay available
CorMedix Inc. (NASDAQ: CRMD) Q3 2025 earnings conference call, held 2025-11-12. Replay captured from the company's public earnings webcast.

LifeSci Advisors
Chief Executive Officer
Executive Vice President and Chief Operating Officer
Executive Vice President and Chief Financial Officer
Analyst, Truist
Analyst, Citizens
Analyst, Lear Inc. Partners
Analyst, HC Wainwright
Analyst, Needham & Company
Good day, and welcome to the Core Medics Third Quarter 2025 Earnings and Corporate Update Conference Call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then one on a touch-tone phone. To withdraw your question, please press star, then two. Please note this event is being recorded. I would now like to turn the conference over to Daniel Ferry of LifeSci Advisors. Please go ahead. Thank you, Operator. Good morning, and welcome to the Corps Medics Third Quarter 2025 Earnings and Corporate Update Conference Call. Leading the call today is Joe Tedisco, Chief Executive Officer of Corps Medics, and he is joined by Liz Hurlburt, EVP and Chief Operating Officer, and Susan Blum, EVP and Chief Financial Officer. In addition, Beth Zelnick-Kaufman, EVP and Chief Legal and Compliance Officer, and Dr. Matt David, EVP and Chief Business Officer, are on the line and will be available during the Q&A session. Before we begin, I would like to remind everyone that during the call, management may make what are known as forward-looking statements within the meaning set forth in the Private Securities Litigation Reform Act of 1995. These statements are statements other than statements of historical fact regarding management's expectations, beliefs, goals, and plans about the company's prospects and future financial position. Actual results may differ materially from the estimates and projections on which these statements are based due to a variety of important factors, including the risks and uncertainties described in greater detail in core medics filings with the SEC, w...